Evaluation of Potential Drug Interactions with AiDKlinik^® in a Random Population Sample

References

• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–1205. doi:10.1001/jama.279.15.1200
   PubMed Web of Science ®Google Scholar
• Knopf H, Grams D. [Medication use of adults in Germany: results of the German health interview and examination survey for adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:868–877. German. doi:10.1007/s00103-013-1667-8
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Drug interactions–principles, examples and clinical consequences. Dtsch Arztebl Int. 2012;109:546–555. doi:10.3238/arztebl.2012.0546
   PubMed Web of Science ®Google Scholar
• Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185–191. doi:10.1016/S0140-6736(07)61092-7
   PubMed Web of Science ®Google Scholar
• Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38:437–453. doi:10.1007/s40264-015-0281-0
   PubMed Web of Science ®Google Scholar
• Schneider KL, Kastenmüller K, Weckbecker K, et al. Potential drug-drug interactions in a cohort of elderly, polymedicated primary care patients on antithrombotic treatment. Drugs Aging. 2018;35:559–568. doi:10.1007/s40266-018-0550-6
   PubMed Web of Science ®Google Scholar
• Schurig AM, Böhme M, Just KS, et al. Adverse Drug Reactions (ADR) and emergencies. Dtsch Arztebl Int. 2018;115:251–258. doi:10.3238/arztebl.2018.0251
   PubMed Web of Science ®Google Scholar
• Alagoz O, Durham D, Kasirajan K. Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions. Pharmacogenomics J. 2016;16:29–36. doi:10.1038/tpj.2015.39
   Web of Science ®Google Scholar
• Meier F, Maas R, Sonst A, et al. Adverse drug events in patients admitted to an emergency Department: an analysis of direct costs. Pharmacoepidemiol Drug Saf. 2015;24:176–186. doi:10.1002/pds.3663
   PubMed Web of Science ®Google Scholar
• Roblek T, Vaupotic T, Mrhar A, et al. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015;71:131–142. doi:10.1007/s00228-014-1786-7
   PubMed Web of Science ®Google Scholar
• Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–551. doi:10.3238/arztebl.2010.0543
   PubMed Web of Science ®Google Scholar
• Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet. 1984;324:564–567. doi:10.1016/S0140-6736(84)90775-X
   Google Scholar
• Schmiedl S, Rottenkolber M, Hasford J, et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. Drug Saf. 2014;37:225–235. doi:10.1007/s40264-014-0141-3
   PubMed Web of Science ®Google Scholar
• Straubhaar B, Krähenbühl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf. 2006;29:79–90. doi:10.2165/00002018-200629010-00006
   PubMed Web of Science ®Google Scholar
• Martin P, Haefeli WE, Martin-Facklam M. A drug database model as a central element for computer-supported dose adjustment within a CPOE system. J Am Med Inform Assoc. 2004;11:427–432. doi:10.1197/jamia.M1296
   PubMed Web of Science ®Google Scholar
• Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9:427–433.
   PubMed Web of Science ®Google Scholar
• Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34:377–386. doi:10.1111/j.1365-2710.2009.01021.x
   PubMed Web of Science ®Google Scholar
• Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25:683–692. doi:10.2165/00002512-200825080-00005
   PubMed Web of Science ®Google Scholar
• Raschi E, Piccinni C, Signoretta V, et al. Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice. Br J Clin Pharmacol. 2015;80:1411–1420. doi:10.1111/bcp.12754
   PubMed Web of Science ®Google Scholar
• Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register. Drug Saf. 2007;30:911–918. doi:10.2165/00002018-200730100-00009
   PubMed Web of Science ®Google Scholar
• Kennedy-Dixon TG, Gossell-Williams M, Hall J, et al. The prevalence of major potential drug-drug interactions at a university health centre pharmacy in Jamaica. Pharm Pract (Granada). 2015;13:601. doi:10.18549/PharmPract.2015.04.601
   PubMedGoogle Scholar
• Naples JG, Marcum ZA, Perera S, et al. Impact of drug-drug and drug-disease interactions on gait speed in community-dwelling older adults. Drugs Aging. 2016;33:411–418. doi:10.1007/s40266-016-0373-2
   PubMed Web of Science ®Google Scholar
• Murtaza G, Khan MY, Azhar S, et al. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2016;24:220–225. doi:10.1016/j.jsps.2015.03.009
   PubMed Web of Science ®Google Scholar
• Tellor KB, Nguyen SN, Bultas AC, et al. Evaluation of the impact of body mass index on warfarin requirements in hospitalized patients. Ther Adv Cardiovasc Dis. 2018;12:207–216. doi:10.1177/1753944718781295
   PubMedGoogle Scholar
• Locquet M, Honvo G, Rabenda V, et al. Adverse health events related to self-medication practices among elderly: a systematic review. Drugs Aging. 2017;34:359–365. doi:10.1007/s40266-017-0445-y
   PubMed Web of Science ®Google Scholar
• Wiedemann G. Big Five – sind 5 Medikamente genug? [Big Five - Are 5 drugs enough?] Klinikarzt. 2018;47:385–387. German. doi:10.1055/a-0654-4493
   Google Scholar